One in four UK prisoners has attention deficit hyperactivity disorder, says report
One in four prisoners in Britain are believed to have attention deficit hyperactivity disorder (ADHD), according to a new report. The figure, which has surprised experts, is five to 10 times higher than its prevalence of 2% to 4% in the general population.
Read MoreIncreased Risk of ADHD in Children Exposed to Maternal Sickle Cell Disease
Children exposed to maternal sickle cell disease were at an increased risk of attention deficit hyperactivity disorder and obesity, according to a new study from Maryland.
Read MoreADHD and Epilepsy: Is There a Link?
Research has helpful insights on why ADHD and epilepsy often occur together and how to approach treatment. Attention deficit hyperactivity disorder (ADHD) and epilepsy often occur together. People living with ADHD have an increased risk of seizures.
Read MoreOlympic Bronze Medalist Withdraws from Race as She Awaits Exemption for ‘Life Changing’ ADHD Medication
Molly Seidel is prioritizing her mental health over everything else — even racing. The U.S. Olympic marathoner, who won a bronze medal at the Tokyo Games in 2020, shared a candid Instagram post on Wednesday detailing why she would not be competing in this weekend’s Mastercard New York Mini 10K.
Read MoreWillpower and ADHD
CONFERENCE REPORTER: “Why is it that people with ADHD can do some specific things that they happen to be really interested in, or where they feel like, if they don’t take care of this right here, right now, something they do not want to see happen is going to happen fast?” Thomas E. Brown, PhD,…
Read MoreADHD at Work: 10 Tips for Thriving at the Office
Living with ADHD can impact your job performance and confidence. But managing your symptoms at work is possible.
Read MoreADHD: Medication alone doesn’t improve classroom learning for children – new research
For decades, many physicians, parents and teachers have believed that stimulant medications help children with ADHD learn because they are able to focus and behave better when medicated. After all, an estimated 6.1 million children in the U.S. are diagnosed with attention-deficit/hyperactivity disorder, and more than 90% are prescribed stimulant medication as the main form…
Read MoreAmy Licis, MD: Restless Leg Syndrome is an Overlooked Cause of Sleep Disturbance
In an interview with HCPLive, expert Amy Licis, MD, MSCI, Associate Professor, Pediatric Neurology and Sleep Medicine, Washington University Department of Neurology, discussed the various sleep disorders that impact children who have autism or attention deficit hyperactivity disorder (ADHD).
Read MoreBeyond Ritalin and Adderall: Examining non-stimulant approaches to ADHD treatment.
KEY POINTS: Methylphenidate and amphetamine are often the go-to medication options for ADHD. However, both methylphenidate and amphetamine have their own risks and concerns. Non-stimulant medications offer hope to those who are not interested in or unable to take stimulants.
Read MoreWhen it comes to ADHD and ASD, the eyes could reveal all
The eyes may be able to signal neurodevelopmental disorders such as ASD and ADHD, according to new research from Flinders University and the University of South Australia. In the first study of its kind, researchers found that recordings from the retina could identify distinct signals for both attention deficit hyperactivity disorder (ADHD) and autism spectrum…
Read MoreThe Youth Mental Health Crisis: Supporting Patients With ASD and ADHD
CONFERENCE REPORTER: “One-third of kids in middle school and high school in North America are struggling socially—one-third,” Elizabeth Laugeson, PsyD, told attendees of the 2022 American Psychiatric Association Annual Meeting. “Do you think they’re all getting services? Probably not. And if you think about the consequences of this, it’s pretty disturbing.”
Read MoreStartup Cerebral Soared on Easy Adderall Prescriptions. That Was Its Undoing.
Online mental-health startup Cerebral Inc. was just getting off the ground in early 2020 when it detected a potential problem in its business model.
Read More